TrimRx's Blog
Ozempic Alcohol Use Disorder — New GLP-1 Research
Emerging research shows GLP-1 medications like Ozempic may reduce alcohol cravings through dopamine modulation in reward pathways — here’s what patients
Ozempic Gambling Addiction — What Patients Need to Know
Emerging reports link Ozempic and GLP-1 medications to compulsive gambling behaviors. Learn the biological mechanism, risk factors, and what to watch for.
Ozempic Compulsive Shopping — Impulse Control Side Effects
Ozempic compulsive shopping links to dopamine pathway disruption affecting impulse control. Learn mechanisms, risk factors, and clinical management
Ozempic Social Anxiety — Does Semaglutide Affect Mental
Semaglutide doesn’t directly cause social anxiety, but rapid weight loss and blood sugar shifts can influence mood and confidence during GLP-1 therapy.
Ozempic Parkinsons — GLP-1 Research & Risk Context
Ozempic shows protective signals against Parkinson’s in early research, but GLP-1 therapy isn’t a prevention tool. Understand the data, mechanism, and
Wegovy Hair Loss — What the Clinical Data Actually Shows
Wegovy can trigger temporary telogen effluvium in some patients. Here’s the mechanism, timeline, and what doctors recommend during GLP-1 treatment.
Stopped Losing Weight on Wegovy? Here’s What Happens Next
Hit a plateau on Wegovy? Weight loss stalls at 3–6 months for 40% of patients. We explain why it happens, what metabolic adaptation means, and how to
Wegovy Plateau 3 Months — Why Weight Stalls & What Works
Weight plateau at 3 months on Wegovy? It’s not medication failure — your body adapted. Here’s the metabolic reason and what actually fixes it.
Wegovy Plateau 6 Months — Why It Happens (And How to Break
Wegovy plateau at 6 months reflects metabolic adaptation—not medication failure. Learn the 3 mechanisms behind stalls and evidence-based strategies to
